PCDHGC5
Protocadherin gamma-C5
Also known as: PCDGM_HUMAN, PCDH-GAMMA-C5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y5F6
- Gene
- PCDHGC5
- Ensembl
- ENSG00000240764
- Chromosome
- 5
- Canonical length
- 944 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Vesicles,Plasma membrane,Cytosol
OverviewNCBI Gene
This gene is a member of the protocadherin gamma gene cluster, one of three related clusters tandemly linked on chromosome five. These gene clusters have an immunoglobulin-like organization, suggesting that a novel mechanism may be involved in their regulation and expression. The gamma gene cluster includes 22 genes divided into 3 subfamilies. Subfamily A contains 12 genes, subfamily B contains 7 genes and 2 pseudogenes, and the more distantly related subfamily C contains 3 genes. The tandem array of 22 large, variable region exons are followed by a constant region, containing 3 exons shared by all genes in the cluster. Each variable region exon encodes the extracellular region, which includes 6 cadherin ectodomains and a transmembrane region. The constant region exons encode the common cytoplasmic region. These neural cadherin-like cell adhesion proteins most likely play a critical role in the establishment and function of specific cell-cell connections in the brain. Alternative splicing has been described for the gamma cluster genes. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
944 residues, UniProt reviewed canonical sequence.
>Q9Y5F6|PCDHGC5
1 MGPKTLPQLA GKWQVLCMLS LCCWGWVSGQ LRYSVVEESE PGTLVGNVAQ DLGLKMTDLL
61 SRRLQLGSEE NGRYFSLSLM SGALAVNQKI DRESLCGAST SCLLPVQVVT EHPLELIRVE
121 VEILDLNDNS PSFATPEREM RISESAASGA RFPLDSAQDP DVGTNTVSFY TLSPNSHFSL
181 NVKTLKDGKP FPELVLEQQL DREAQARHQL VLTAVDGGTP ARSGTTLISV IVLDINDNAP
241 TFQSSVLRVG IPENAPIGTL LLRLNATDPD EGTNGQLDYS FGDHTSEAVR NLFGLDPSSG
301 AIHVLGPIDF EESRFYEIHA RARDQGQPAM EGHCVIQVDV GDVNDNAPEV LLASLANPVL
361 ESTPVGTVVG LFNVRDRDSG RNGEVSLDIS PDLPFQIKPS ENHYSLLTSQ PLDREATSHY
421 IIELLASDAG SPSLHKHLTI RLNISDVNDN APRFNQQLYT AYILENRPPG SLLCTVAASD
481 PDTGDNARLT YSIVGNQVQG APASSFVYVN PEDGRIFAQR TFDYELLQML QIVVGVRDSG
541 SPPLHANTSL HVFVLDENDN APAVLHPRPD WEHSAPQRLP RSAPPGSLVT KVTAVDADAG
601 HNAWLSYSLL PQSTAPGLFL VSTHTGEVRT ARALLEDDSD TQQVVVLVRD NGDPSLSSTA
661 TVLLVLEDED PEEMPKSSDF LIHPPERSDL TLYLIVALAT VSLLSLVTFT FLSAKCLQGN
721 ADGDGGGGQC CRRQDSPSPD FYKQSSPNLQ VSSDGTLKYM EVTLRPTDSQ SHCYRTCFSP
781 ASDGSDFTFL RPLSVQQPTA LALEPDAIRS RSNTLRERSQ QAPPNTDWRF SQAQRPGTSG
841 SQNGDDTGTW PNNQFDTEML QAMILASASE AADGSSTLGG GAGTMGLSAR YGPQFTLQHV
901 PDYRQNVYIP GSNATLTNAA GKRDGKAPAG GNGNKKKSGK KEKKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PCDHGC5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 28 nTPM
- basal ganglia: 12 nTPM
- hippocampal formation: 5.2 nTPM
- heart muscle: 4.7 nTPM
- amygdala: 3.5 nTPM
- cerebellum: 2.8 nTPM
Single-cell type
- cardiomyocytes: 0.1 nCPM
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
- alveolar cells type 1: 0 nCPM
- alveolar cells type 2: 0 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hippocampal formation: 92 nTPM
- cerebral cortex: 58 nTPM
- basal ganglia: 49 nTPM
- amygdala: 42 nTPM
- white matter: 33 nTPM
- hypothalamus: 22 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PCDHGC5.
Disease | ImmuneIEDB
Conditions an epitope on PCDHGC5 was assayed in.
- glioblastoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.74
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.54
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell adhesion
- homophilic cell adhesion via plasma membrane adhesion molecules
- negative regulation of neuron apoptotic process
- nervous system development
- synapse organization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cadherin-like
- Cadherin, N-terminal
- Cadherin-like superfamily
- Cadherin conserved site
- Cadherin, C-terminal catenin-binding domain
- Cadherin, cytoplasmic C-terminal domain
- Protocadherin/Cadherin-related Cell Adhesion
- Cadherin domain
- Cadherin-like
- Cadherin C-terminal cytoplasmic tail, catenin-binding region
- Cadherin cytoplasmic C-terminal
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PCDHGC5 as an antibody target. Whether an autoantibody or antibody against PCDHGC5 could matter depends on whether native PCDHGC5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PCDHGC5 is annotated at the cell surface, where native PCDHGC5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PCDHGC5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...